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Fluorescent probes play a key role in modern biomedical research. As compared to inorganic quantum dots (QDs) composed 
with heavy metal elements, organic dye-based fluorescent nanoparticles have higher biocompatibility and are richer in variety. 
However, traditional organic fluorophores tend to quench fluorescence upon aggregation, which is known as aggregation-    
caused quenching (ACQ) effect that hinders the fabrication of highly emissive fluorescent nanoparticles. In this work, we 
demonstrate the synthesis of organic fluorescent dots with aggregation-induced emission (AIE) in far-red/near-infrared 
(FA/NIR) region. A conventional ACQ-characteristic fluorescent dye, 3,4:9,10-tetracarboxylic perylene bisimide (PBI), is 
converted into an AIE fluorogen through attaching two tetraphenylethylene (TPE) moieties. The fluorescent dots with surface 
folic acid groups are fabricated from PBI derivative (DTPEPBI), showing specific targeting effect to folate receptor-overexpressed 
cancer cells. In vivo studies also suggest that the folic acid-functionalized AIE dots preferentially accumulate in the tumor site 
through enhanced permeability and retention (EPR) effect and folate receptor-mediated active targeting effect. The low cyto-
toxicity, good FR/NIR contrast and excellent targeting ability in in vitro/in vivo imaging indicate that the AIE dots have great 
potentials in advanced bioimaging applications. 




1  Introduction 
In modern bioimaging applications, fluorescent techniques 
have been proven to be powerful tools in both fundamental 
research and practical applications [1]. Fluorescent probes 
play the essential role in bioimaging tasks to ensure desired 
fluorescence output with high sensitivity, motivating re-
searchers to make great efforts to explore new generations 
of probes with high brightness, good photostability and fea-
sible synthetic methods. Among various fluorescent probes, 
inorganic quantum dots (QDs) have shown great advantages 
in terms of better photostability and large Stokes shifts as 
compared to small organic dye molecules [2]. However, the 
intrinsic components of hazardous heavy metal elements 
may cause potential toxic issue [3], which needs to be fully 
understood before using such QD probes for in vivo imag-
ing studies. Moreover, the fluorescence of QDs tends to be 
diminished in acidic environment [4], compromising the 
reliability during data analysis. As compared to inorganic 
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QDs, various organic dye-loaded fluorescent nanoparticles 
have shown superior cytocompatibility and fluorescence sta-
bility to the QDs. However, conventional organic dyes   
always suffer weakened or annihilated fluorescence upon 
aggregation, which is known as aggregation-caused quench-
ing (ACQ) [5]. Hence, the booming development in biomed-
ical applications requires novel class of fluorescent probes 
with the hope to overcome the shortcomings of the inorganic 
QD probes and organic dye-loaded fluorescent nanoparticles. 
Recently, we have reported several fluorogens that ex-
hibited unique aggregation-induced emission (AIE) charac-
teristics, which are directly opposite to ACQ and will 
greatly benefit the formulation of highly fluorescent nano-
particles [6, 7]. The AIE fluorogens are non-emissive when 
they are well-dissolved in solution but become highly emis-
sive upon aggregation due to the restriction of intramolecu-
lar rotations (RIR) that activates radiative decay channels 
[8]. We found that simply attaching an iconic AIE unit, 
tetraphenylethene (TPE), to various conventional ACQ 
chromophores will facilitate the conversion to AIE ones, 
which offers a feasible and efficient approach to synthesize 
AIE fluorogens [9]. Additionally, using biocompatible dis-
tearoyl-sn-glycero-3-phosphoethanolamine-poly(ethylene  
glycol) (DSPE-PEG) derivatives as the encapsulation matrix, 
we have demonstrated that the AIE dots greatly outperform 
inorganic QD probes in in vitro and in vivo long-term cell 
tracing applications [10]. These results strongly suggest that 
the AIE fluorogens are promising candidates in the devel-
opment of next generation of organic fluorescent dots. 
In this contribution, we report the fabrication of AIE dots 
with far-red/near-infrared (FR/NIR) emission and demon-
strate their performance in targeted imaging ability using a 
folate receptor-overexpressed tumor-baring mouse model. 
Through attaching TPE to a perylene-3,4:9,10-tetracarboxylic 
bisimide (PBI) derivative with typical ACQ effect, the ob-
tained fluorogen shows pronounced AIE feature with effi-
cient FR/NIR emission upon aggregation. Using the mixture 
of DSPE-PEG and DSPE-PEG-Folate as the encapsulation 
matrix, the obtained folate-functionalized AIE dots show 
higher targeting ability to folate receptor-overexpressed 
cancer cells and tumors as compared to AIE dots using 
DSPE-PEG alone during dot fabrication. This study opens a 
new window to synthesize fluorescent dots with FR/NIR 
emission and good biocompatibility to benefit the develop-
ment of advanced imaging probes. 
2  Experimental 
2.1  Materials 
[N,N′-dicyclohexyl-1,7-bis(4′-(1′,2′,2′-triphenyl)vinyl)phenyl- 
perylene-3,4:9,10-tetracarboxylic bisimide] (DTPEPBI) was 
synthesized according to literature [11]. 1,2-Distearoyl-      
sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene  
glycol)-2000] (DSPE-PEG2000) was a gift from Lipoid 
GmbH (Ludwigshafen, Germany). DSPE-PEG5000-Folate 
was a commercial product of Avanti Polar Lipids, Inc. Tet-
rahydrofuran (THF), 4',6-diamidino-2-phenylindole (DAPI), 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT), penicillin-streptomycin solution, and trypsin-     
EDTA solution were purchased from Sigma-Aldrich. Fetal 
bovine serum (FBS) was purchased from Gibco (Lige 
Technologies, Ag, Switzerland). Milli-Q water was supplied 
by Milli-Q Plus System (Millipore Corporation, Breford, 
USA). MCF-7 cells and H22 cells were provided by Ameri-
can Type Culture Collection. 
2.2  Synthesis of DTPEPBI based fluorescent dots 
A THF solution (0.5 mL) containing 1 mg of DTPEPBI and 
2 mg of mixture of DSPE-PEG2000 and DSPE-PEG5000-     
Folate (molar percentage ratio of DSPE-PEG5000-Folate was 
0% and 50%, respectively) was poured into 10 mL of 90% 
(v/v) water/THF solution. This was followed by sonication 
for 60 seconds at 12 W output using a microtip probe soni-
cator (XL2000, Misonix Incorporated, NY). The emulsion 
was then stirred at room temperature overnight to evaporate 
THF. AIE dots and Folate-AIE dots are assigned to 
DTPEPBI based fluorescent dots prepared without and with 
DSPE-PEG5000-Folate, respectively. The obtained solution 
was filtered using a 0.22 μm syringe-driven filter to collect 
the products. 
2.3  Characterization methods 
The UV-Vis spectra of dot suspensions in water were rec-
orded on a Shimadzu UV-1700 spectrometer. The fluores-
cence spectra were measured using a fluorometer (LS-55, 
Perkin Elmer, USA). Average particle size and size distri-
bution of the dots were determined by laser light scattering 
(LLS) with particle size analyzer (90 Plus, Brookhaven In-
struments Co. USA) at a fixed angle of 90° at room temper-
ature. The morphology of dots was also studied by high-    
resolution transmission electron microscope (HR-TEM, 
JEM-2010F, JEOL, Japan).  
2.4  Cell culture 
Cells were cultured in folate-free Dulbecco's Modified Ea-
gle Medium (DMEM) containing 10% fetal bovine serum 
and 1% penicillin streptomycin at 37 °C in a humidified 
environment containing 5% CO2. Before experiment, the 
cells were pre-cultured until confluence was reached. 
2.5  In vitro fluorescence imaging 
MCF-7 breast cancer cells were cultured in the confocal 
imaging chambers (LAB-TEK, Chambered Coverglass 
System) at 37 °C. After 80% confluence, the medium was 
removed and the adherent cells were washed twice with 1× 
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PBS buffer. The AIE dots and Folate-AIE dots in FBS-free 
DMEM medium at 2 M of DTPEPBI were then added to 
the chambers, respectively. After incubation for 2 h, the 
cells were washed three times with 1× PBS buffer and then 
fixed by 75% ethanol for 20 minutes, which were further 
washed twice with 1× PBS buffer and stained by DAPI for 
10 min. The cell monolayer was then washed twice with 1× 
PBS buffer and imaged by confocal laser scanning micro-
scope (CLSM, Zeiss LSM 410, Jena, Germany) with imag-
ing software (Olympus Fluoview FV1000) under the same 
experimental condition. The fluorescence signal from dots 
was collected at 543 nm excitation with a 560 nm longpass 
barrier filter. For flow cytometry analysis, two groups of cells 
were trypsinized and fixed in 75% ethanol after incubation 
with AIE-dots and Folate-AIE dots, respectively. The cells 
were then suspended in 1 × PBS buffer and the fluorescence 
intensities were analyzed using Cyan-LX (DakoCytomation). 
The histogram of each sample was obtained by counting 
10,000 events (ex = 488 nm, 750 nm longpass filter). 
2.6  Cytotoxicity studies 
The cytotoxicity of AIE dots and Folate-AIE dots was 
evaluated using MCF-7 cells through MTT assay. In brief, 
MCF-7 cells were seeded in 96-well plates (Costar, IL,  
USA) at a density of 2 × 104 cells/mL. After 48 h incubation, 
the medium was discarded and AIE dots and Folate-AIE 
dots in DMEM with various concentrations were added into 
each sample wells for further incubation at 37 °C, respec-
tively. To eliminate the UV absorption interference of 
DTPEPBI at 570 nm, the cells incubated with a series of 
AIE dots at the same doses but not post-treated by MTT 
were used as the control. After the designated time intervals, 
the sample wells were washed twice with 1× PBS buffer 
and 100 L of freshly prepared MTT (0.5 mg/mL) solution 
in culture medium was added into each well. After 3 h in-
cubation in the incubator, the MTT medium solution was 
carefully removed, followed by addition of 100 L of 
DMSO into each well and the plate was gently shaken for 
10 min at room temperature to dissolve all the precipitates 
formed. The absorbance of MTT at 570 nm was monitored 
by the microplate reader (Genios Tecan). Cell viability was 
expressed by the ratio of the absorbance of the cells incu-
bated with fluorescent dot suspension to that of the cells 
incubated with culture medium only. 
2.7  In vivo fluorescence imaging  
All animal studies were performed in compliance with 
guidelines set by the Animal Care Committee at Drum-     
Tower Hospital. 0.1 mL of H22 cell suspension containing  
5 × 106–6 × 106 cells were injected subcutaneously to ICR 
mice (average body weight of 25 g) at the left axilla. When 
the tumor volume reached a mean size of about 300 mm3, 
the mice were intravenously injected with 250 L of AIE 
dots and Folate-AIE dots, respectively, at the dye concen-
tration of 4 mg/kg animal. Subsequently, the mice were 
anesthetized and placed on an animal plate heated to 37 °C. 
The biodistribution in mice was imaged using the Maestro 
in vivo fluorescence imaging system (CRi, Inc.). The light 
with a central wavelength at 523 nm was selected as the 
excitation source. In vivo spectral imaging from 560 to 900 
nm (10 nm step) was conducted with an exposure time of 
150 ms for each image frame. Auto-fluorescence was re-
moved by using the spectral unmixing software. Scans were 
carried out at 2, 8 and 24 h post-injection. 
3  Results and discussion 
The fluorescent dots with aggregation-induced emission 
feature were synthesized through a nanoprecipitation method 
[12]. Using a mixture of 1,2-distearoyl-sn-glycero-3-    
phosphoethanolamine-N-[methoxy(polyethylene glycol)-  
2000] (DSPE-PEG2000) and DSPE-PEG5000-Folate as the 
encapsulation matrix, the fluorescent dots with good bio-
compatibility and surface folic acid groups for folate-      
receptor overexpressed cancer cell targeting were obtained. 
Folate-AIE dots and AIE dots represent fluorescent dots that 
were formulated with encapsulation matrix containing 50% 
and 0% of DSPE-PEG5000-Folate, respectively. During for-
mation, the hydrophobic DSPE segments tend to be em-
bedded into the hydrophobic core with DTPEPBI while the 
hydrophilic PEG-folate chains extend into the aqueous 
phase.  
Laser light scattering (LLS) result suggests that the vol-
ume average hydrodynamic diameter of Folate-AIE dots is 
52 ± 3 nm (Figure 1(a)), which is similar to that of the AIE 
dots (49 ± 2 nm). The morphology of Folate-AIE dots were 
studied by high-resolution transmission electron microscopy 
(HR-TEM), which is shown as the inset in Figures 1(a). The 
black dots suggest that the spherical Folate-AIE dots can be 
clearly distinguished due to the high electron density of 
DTPEPBI molecules. Figure 1(b) shows the UV-Vis absorp-
tion and photoluminescence (PL) spectra of Folate-AIE dots 
in water, suggesting that the Folate-AIE dots have an emis-
sion maximum at 734 nm, which is similar to that of AIE 
dots in water (732 nm). The quantum yield of Folate-AIE 
dots in water is measured to be 3%, using rhodamine 6G in 
ethanol as the standard. The intense emission of Folate-AIE 
dots in FR/NIR window will greatly benefit in vivo experi-
ments with deep tissue penetration depth and minimized 
autofluorescence interference. 
MCF-7 breast cancer cells that are known to have high 
folate receptor expression level in cell membrane were 
chosen to evaluate the targeting ability of Folate-AIE dots 
over AIE dots without surface folic acid groups [13]. The 
effect of surface folic acid groups on internalization effi-
ciency of the dots by MCF-7 breast cancer cells was inves-
tigated using confocal laser scanning microscopy. Figures  
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Scheme 1  Chemical structures of DTPEPBI, DSPE-PEG2000 and DSPE-PEG5000-Folate. 
 
Figure 1  (a) Particle size distribution of Folate-AIE dots in water studied by laser light scattering. The inset shows HR-TEM image of Folate-AIE dots; (b) 
UV-Vis absorption and PL spectra of Folate-AIE dots in water (excited at 543 nm). 
2(a) and (b) show the confocal images of MCF-7 breast 
cancer cells after incubation with AIE dots and Folate-AIE 
dots in freshly prepared culture medium for 2 h at DTPEPBI 
concentration of 2 M, respectively. The cell nuclei were 
stained with 4′,6-diamidino-2-phenylindole (DAPI). These 
images were taken upon excitation at 543 nm with a 560 nm 
longpass barrier filter. It should be noted that no auto fluo-
rescence from the cell itself can be detected under the same 
experimental condition (Figure 2(c)). Comparison between 
Figures 2(a) and (b) suggests that the fluorescence intensity 
from cell cytoplasm after incubation with Folate-AIE dots is 
higher than that after incubation with AIE dots. The higher 
fluorescence intensity of MCF-7 cancer cells in Figure 2(a) 
as compared to that in Figure 3(b) suggests that more fluo-
rescent dots are internalized into the cells due to specific 
interactions between folic acid on Folate-AIE dot surface 
and folate receptors in the cancer cell membrane, which 
should favor folate receptor-mediated endocytosis [14, 15]. 
The flow cytometry histograms of MCF-7 cancer cells after 
incubation with AIE dots and Folate-AIE dots are shown in 
Figure 2(d), indicating that the average fluorescence inten-
sity of each cell incubated with Folate-AIE dots is ~1.3 
times higher as compared to that upon incubation with AIE 
dots. In addition, the cytotoxicity of both AIE dots and  
Folate-AIE dots was evaluated through methylthiazolyldi-
phenyltetrazolium bromide (MTT) assays. The results sug-
gest that the metabolic viability of MCF-7 cancer cells after 
incubation with fluorescent dots at 2, 4 and 8 μM of 
DTPEPBI for 48 h remains above 90%, suggesting both 
AIE dots and Folate-AIE dots are of low cytotoxicity (Fig-
ure 2(e)).  
The performance of Folate-AIE dots in in vivo imaging 
was further investigated on a folate receptor-overexpressed 
tumor-bearing mouse model, using AIE dots without folic 
acids as the control. The animal model was established 
through subcutaneous inoculation of murine hepatic H22 
cancer cells into the right flank of each mouse. When the 
tumor volume reached about 300 mm3, the mice were in- 
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Figure 2  Confocal images of MCF-7 cancer cells after incubation with AIE dots (a) and Folate-AIE dots (b) for 2 h at 37 °C ([DTPEPBI] = 2 M). The 
fluorescence signal was recorded under excitation at 543 nm with a 560 nm longpass barrier filter. The blue signal indicates cell nuclei stained by DAPI; (c) 
confocal image of the pristine cells without incubation fluorescent dots. All the images share the same scale bar; (d) flow cytometry histograms of pure 
MCF-7 cells (control) and cells treated with AIE dots and Folate-AIE dots; (e) metabolic viability of MCF-7 cells after 48 h incubation with AIE dots and 
Folate-AIE dots at the DTPEPBI concentrations of 2, 4 and 8 M, respectively. 
 
Figure 3  In vivo fluorescence imaging of H22 tumor-bearing mice after 
intravenous injection of AIE dots (a) and Folate-AIE dots (b), respectively. 
The red circle indicates the tumor site. 
travenously injected with AIE dots and Folate-AIE dots 
through tail vain, respectively. After designated time inter-
vals upon injection, the mice were imaged by a Maestro EX 
in vivo fluorescence imaging system with a central wave-
length at 523 nm as the excitation source. Figure 3(a) shows 
the in vivo distribution of AIE dots without folic acids in the 
tumor-bearing mouse at 2, 8 and 24 h post-injection. The FL 
intensities are indicated with different colors, and the order 
of red, orange, yellow, green, and blue refers to a successive 
decrease in intensity. Obvious fluorescence signal is ob-
served in the area of tumor tissue at all the time points, 
suggesting that AIE dots have efficiently accumulated in 
tumor through enhanced permeability and retention (EPR) 
effect [16]. In addition, strong fluorescence from the liver 
region is also observed, which implicates that a portion of 
fluorescent dots in the blood circulation tend to be enriched 
in the liver, due to reticuloendothelial system (RES) uptake 
[17]. On the other hand, the specific tumor targeting ability 
of Folate-AIE dots is also evaluated on the same tu-
mor-bearing mouse model (Figure 3(b)). Much higher fluo-
rescence intensity is shown in the tumor tissue of Fo-
late-AIE dot-treated mouse as compared to that of AIE 
dot-treated mouse at all the time points, demonstrating the 
specific targeting ability of Folate-AIE dots to the tumor 
that contains folate receptor-overexpressed cancer cells in a 
living body. Noteworthy is that the ratio between fluores-
cence intensity from the tumor tissue and that from the liver 
tissue upon administration of Folate-AIE dots is signifi-
cantly enhanced as compared to that upon administration of 
AIE dots. These results clearly indicate that Folate-AIE dots 
can be used as an effective fluorescent probe for in vivo 
tumor diagnosis with high specificity and good fluorescence 
contrast. 
 Li K, et al.   Sci China Chem   September (2013) Vol.56 No.9 1233 
4  Conclusion 
In this work, we successfully synthesized FR/NIR organic 
fluorescent dots using luminogens with aggregation-induced 
emission (AIE) feature as the core and biocompatible 
DSPE-PEG derivatives as the encapsulation matrix. 
Through mixing DSPE-PEG-Folate with DSPE-PEG, Fo-
late-AIE dots with surface folic acid groups were obtained 
to facilitate targeted imaging studies. In vitro studies using 
MCF-7 cancer cells with high folate receptor overexpres-
sion as a model suggest that the folic acid-functionalized 
organic dots have higher living cell internalization efficien-
cy as compared to AIE dots without surface folic acids, due 
to folate-receptor mediated endocytosis. The targeting abil-
ity of Folate-AIE dots to folate receptor-overexpressed tu-
mor was also investigated on an animal model, indicating 
that Folate-AIE dots preferentially accumulated at the tumor 
site and the emission profile of the dots in FR/NIR region is 
greatly beneficial to in vivo fluorescence imaging. These 
results demonstrate the great potential of DTPEPBI-based 
Folate-AIE dots in cancer diagnosis with high specificity 
and good fluorescence contrast for in vivo studies. In future, 
such AIE dots with incorporation of therapeutic reagents 
will provide a promising platform to construct multifunc-
tional dots for tumor diagnosis and treatment. 
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